Stock Price Forecast

April 19, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading EXACT SCIENCES CORP chart...

About the Company

Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer.

Exchange

Nasdaq

$2B

Total Revenue

5K

Employees

$11B

Market Capitalization

-52.27

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $EXAS News

Here’s Why Exact Sciences Corporation (EXAS) Declined in Q1

8d ago, source: InvestingChannel on MSN

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A ...

Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes

9d ago, source:

Exact Sciences Corp. (Nasdaq: EXAS) (the "Company"), a leading provider of cancer screening and diagnostic tests, today ...

Exact Sciences' (EXAS) Oncoguard Esophagus Test Looks Promising

17d ago, source: Zacks.com on MSN

Exact Sciences Corporation EXAS recently reported a promising outcome for the non-endoscopic Oncoguard Esophagus test, developed in collaboration with the Mayo Clinic Comprehensive Cancer Center. The ...

Should You Hold ON Semiconductor Corporation (ON)?

8d ago, source: InvestingChannel on MSN

Artisan Mid Cap Fund featured stocks like ON Semiconductor Corporation (NASDAQ:ON) in the first quarter 2024 investor letter.

Buy Rating Affirmed for Exact Sciences on Promising Multi-Cancer Detection Technology

10d ago, source:

Leerink Partners analyst Puneet Souda has maintained their bullish stance on EXAS stock, giving a Buy rating on April 3. Puneet Souda has ...

Investors: What’s The Real Deal With Exact Sciences Corp. (NASDAQ: EXAS)

18d ago, source:

The trading price of Exact Sciences Corp. (NASDAQ:EXAS) closed higher on Monday, April 01, closing at $70.41, 1.95% higher than its previous close. In examining the 52-week price action we see that ...

Seekin, Exact liquid biopsies advance early cancer detection

10d ago, source: BioWorld

Exact Sciences Corp., Seekin Inc. and Serum Detect Inc. presented encouraging results for the field of multicancer early ...

Salmonella outbreak linked to fresh basil sold at Trader Joe's stores in multiple states

1d ago, source:

The organic basil was sold in 2.5-ounce, clamshell-style containers under the name Infinite Herbs at Trader Joe's in 29 ...

MarketMasterAI’s Top 500 Stocks: April 2024

10d ago, source:

InvestorPlace - Stock Market News, Stock Advice & Trading Tips In January, I published MarketMasterAI’s top 500 stocks to buy ...

Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner

24d ago, source:

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it has ...

Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2024 Update

1d ago, source:

ARK Invest's 13F portfolio value decreased by 15% this quarter, with the number of holdings increasing from 223 to 230. Click ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...